Literature DB >> 31961408

Trends in Buprenorphine Treatment in the United States, 2009-2018.

Mark Olfson1, Victoria Shu Zhang2, Michael Schoenbaum3, Marissa King2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31961408      PMCID： PMC6990679          DOI： 10.1001/jama.2019.18913

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015.

Authors:  Andrew W Roberts; Brendan Saloner; Stacie B Dusetzina
Journal:  Psychiatr Serv       Date:  2018-05-08       Impact factor: 3.084

2.  Trends In Buprenorphine Prescribing By Physician Specialty.

Authors:  Hefei Wen; Tyrone F Borders; Janet R Cummings
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

3.  Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States.

Authors:  Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

4.  US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016.

Authors:  Julie R Gaither; Veronika Shabanova; John M Leventhal
Journal:  JAMA Netw Open       Date:  2018-12-07
  4 in total
  35 in total

1.  The Broken Care Continuum for Young Adults With Opioid Addiction.

Authors:  Scott E Hadland
Journal:  J Adolesc Health       Date:  2020-12       Impact factor: 5.012

2.  Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program.

Authors:  Andrea Jakubowski; Tiffany Lu; Frank DiRenno; Benjamin Jadow; Angela Giovanniello; Shadi Nahvi; Chinazo Cunningham; Aaron Fox
Journal:  J Subst Abuse Treat       Date:  2020-09-22

3.  Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020.

Authors:  Jonathan Cantor; David Powell; Aaron Kofner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

4.  Perioperative Management of Buprenorphine/Naloxone in a Large, National Health Care System: a Retrospective Cohort Study.

Authors:  Jessica J Wyse; Anders Herreid-O'Neill; Jacob Dougherty; Sarah Shull; Katherine Mackey; Kelsey C Priest; Honora Englander; Jessica Thoma; Travis I Lovejoy
Journal:  J Gen Intern Med       Date:  2021-09-20       Impact factor: 6.473

5.  Age disparities in six-month treatment retention for opioid use disorder.

Authors:  Carrie M Mintz; Ned J Presnall; John M Sahrmann; Jacob T Borodovsky; Paul E A Glaser; Laura J Bierut; Richard A Grucza
Journal:  Drug Alcohol Depend       Date:  2020-06-18       Impact factor: 4.492

6.  Commentary on Fishman et al. : Youth and family-centered care for young adults with opioid use disorder.

Authors:  Sarah M Bagley; Scott E Hadland
Journal:  Addiction       Date:  2020-12-02       Impact factor: 6.526

7.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

8.  Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial.

Authors:  Li-Tzy Wu; William S John; Eric D Morse; Steve Adkins; Jennifer Pippin; Robert K Brooner; Robert P Schwartz
Journal:  Addiction       Date:  2021-08-16       Impact factor: 6.526

9.  The Association Between Scope of Practice Regulations and Nurse Practitioner Prescribing of Buprenorphine After the 2016 Opioid Bill.

Authors:  Thuy Nguyen; Ulrike Muench; Barbara Andraka-Christou; Kosali Simon; W David Bradford; Joanne Spetz
Journal:  Med Care Res Rev       Date:  2021-04-01       Impact factor: 3.929

10.  High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.

Authors:  Andrew A Herring; Aidan A Vosooghi; Joshua Luftig; Erik S Anderson; Xiwen Zhao; James Dziura; Kathryn F Hawk; Ryan P McCormack; Andrew Saxon; Gail D'Onofrio
Journal:  JAMA Netw Open       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.